SHSE:688091'
s FCF Margin % Range Over the Past 10 Years
Min: -1273.34 Med: -23.4 Max: 31.74
Current: -34.32
During the past 9 years, the highest FCF Margin % of Shanghai Yizhong Pharmaceutical Co was 31.74%. The lowest was -1273.34%. And the median was -23.40%.
SHSE:688091's FCF Margin % is ranked worse than 87.13% of 956
companies
in the Drug Manufacturers industry
Industry Median: 2.48
vs SHSE:688091: -34.32
Shanghai Yizhong Pharmaceutical Co FCF Margin % Related Terms
Shanghai Yizhong Pharmaceutical Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Yizhong Pharmaceutical Co FCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Yizhong Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Yizhong Pharmaceutical Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Yizhong Pharmaceutical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai Yizhong Pharmaceutical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Yizhong Pharmaceutical Co (SHSE:688091) has a FCF Margin % of 2.92% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Yizhong Pharmaceutical Co and its competitors. According to the industry distribution chart, Shanghai Yizhong Pharmaceutical Co ranks #833 out of 956 companies in the Drug Manufacturers industry, placing it in the top 87.1%.
Is Shanghai Yizhong Pharmaceutical Co's FCF Margin % too high?
Shanghai Yizhong Pharmaceutical Co's current FCF Margin % is 2.92%. The Drug Manufacturers industry median FCF Margin % is 2.48. Shanghai Yizhong Pharmaceutical Co's value of 2.92% is 17.7% above this industry median. Based on the distribution chart, Shanghai Yizhong Pharmaceutical Co ranks #833 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shanghai Yizhong Pharmaceutical Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Yizhong Pharmaceutical Co's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai Yizhong Pharmaceutical Co ranks #833 out of 956 companies for FCF Margin %. This places Shanghai Yizhong Pharmaceutical Co in the lower half of its industry. The industry median FCF Margin % is 2.48. Shanghai Yizhong Pharmaceutical Co's value of 2.92% is 17.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Yizhong Pharmaceutical Co's current FCF Margin % of 2.92% is 17.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Yizhong Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Yizhong Pharmaceutical Co's current FCF Margin % is 2.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Yizhong Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Yizhong Pharmaceutical Co (SHSE:688091) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥49.38, compared to a current price of ¥40.20 — trading 18.6% below its estimated fair value. The current FCF Margin % is 2.92% and 17.7% above the Drug Manufacturers industry median of 2.48. Shanghai Yizhong Pharmaceutical Co's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shanghai Yizhong Pharmaceutical Co (SHSE:688091), the current FCF Margin % is 2.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Yizhong Pharmaceutical Co (SHSE:688091) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Yizhong Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥40.20 is trading 18.6% below its estimated GF Value™ of ¥49.38.
GuruFocus considers Shanghai Yizhong Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for SHSE:688091:
FCF Margin %: 2.92%
GF Value™: ¥49.38 vs. price of ¥40.20 (18.6% below fair value)
Industry Position: 17.7% above the Drug Manufacturers median (#833 of 956)
No single metric tells the full story. See the SHSE:688091 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Yizhong Pharmaceutical Co Business Description
Shanghai Yizhong Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating research and development, production and sales. It is committed towards the development of new dosage forms of anti-tumor drugs and related products.
60GF Score
Get the complete analysis for SHSE:688091
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688091 has been successfully added to your 
